SCHEMBL28284095

SCHEMBL28284095

Cc1cc(NC(=O)O)ccc1Nc1ccnc(-c2cccnc2)n1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 3/20 0.59
▸ MAPT P10636 1/20 0.59
▸ HTT P42858 1/20 0.59
▸ CYP1A2 P05177 4/20 0.58
▸ IDE P14735 1/20 0.55
▸ CYP2C9 P11712 3/20 0.55
▸ CYP2C19 P33261 3/20 0.55
▸ CYP3A4 P08684 2/20 0.55
▸ SMN1; SMN2 Q16637 3/20 0.53
▸ XBP1 P17861 1/20 0.53
▸ STAT3 P40763 1/20 0.53
▸ GSK3A P49840 1/20 0.53
▸ GSK3B P49841 1/20 0.53
▸ CDK5 Q00535 1/20 0.53
▸ CDK5R1 Q15078 1/20 0.53
▸ PPARG P37231 1/20 0.51
▸ TDP1 Q9NUW8 1/20 0.51
▸ NR2E3 Q9Y5X4 1/20 0.51
▸ NCOR2 Q9Y618 1/20 0.51
▸ ABL1 P00519 6/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19553909 0.87 CYP1A2 (0.53) KMT2AMAPTHTTCYP1A2IDE
SCHEMBL22628312 0.87 PRKCA (0.54) KMT2AMAPTHTTCYP1A2IDE
SCHEMBL19554542 0.81 ABL1 (0.53) KMT2AMAPTHTTCYP1A2IDE
SCHEMBL28884641 0.81 CYP1A2 (0.57) KMT2AMAPTHTTCYP1A2IDE
SCHEMBL29933958 0.81 CYP1A2 (0.57) KMT2AMAPTHTTCYP1A2IDE
SCHEMBL21004279 0.80 CYP1A2 (0.53) KMT2AMAPTHTTCYP1A2IDE
SCHEMBL21004557 0.79 CYP1A2 (0.46) KMT2AMAPTHTTCYP1A2IDE
SCHEMBL21004280 0.79 CYP1A2 (0.49) KMT2AMAPTHTTCYP1A2IDE
SCHEMBL31359359 0.77 CYP1A2 (0.56) KMT2AMAPTHTTCYP1A2IDE
SCHEMBL15966858 0.77 AURKA (0.63) KMT2AMAPTHTTCYP1A2IDE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109415343-A For treating substituted 2,4- diamino-quinoline of proliferative diseases 基因科学医药公司 2019-03-01 — — CN disclosed
Send feedback